Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Blood
; 137(24): 3454-3459, 2021 06 17.
Article
in En
| MEDLINE
| ID: mdl-33881502
Full text:
1
Database:
MEDLINE
Main subject:
Lymphoma, Large B-Cell, Diffuse
/
Receptors, Chimeric Antigen
Limits:
Humans
Language:
En
Journal:
Blood
Year:
2021
Type:
Article
Affiliation country:
Israel